-
EP1710300
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1710300
| EP1710300 - HIGHLY SAFE SMALLPOX VACCINE VIRUS AND VACCINIA VIRUS VECTOR [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.01.2013 Database last updated on 04.11.2024 | Most recent event Tooltip | 25.01.2013 | Application deemed to be withdrawn | published on 27.02.2013 [2013/09] | Applicant(s) | For all designated states National University Corporation Hokkaido University 8, Kita 8-jyo Nishi 5-chome Kita-ku Sapporo-shi, Hokkaido 060-0808 / JP | [N/P] |
| Former [2009/31] | For all designated states National University Corporation Hokkaido University 8, Kita 8-jyo Nishi 5-chome Kita-ku Sapporo-shi, Hokkaido 060-0808 / JP | ||
| Former [2006/41] | For all designated states Hokkaido Technology Licensing Office Co., Ltd. 7F, Kita Bldg., 8-1, Kita 7 Jou Nishi 2-chome, Kita-ku Sapporo-Shi Hokkaido 060-0807 / JP | Inventor(s) | 01 /
SHIDA, Hisatoshi, Karumuhokudaimae 1001 21-368, Kita 16 Jou Nishi 4-chome, Kita-ku Sapporo-shi, Hokkaido 001-0016 / JP | 02 /
KIDOKORO, Minoru Musashino-jutaku 12-201 2-36-1, Gakuen Musashimurayama-shi, Tokyo 208-0011 / JP | [2006/41] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [2008/35] | Vossius & Partner Siebertstrasse 3 81675 München / DE | ||
| Former [2006/41] | Vossius & Partner Siebertstrasse 4 81675 München / DE | Application number, filing date | 03777318.1 | 05.12.2003 | [2006/41] | WO2003JP15632 | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005054451 | Date: | 16.06.2005 | Language: | EN | [2005/24] | Type: | A1 Application with search report | No.: | EP1710300 | Date: | 11.10.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.06.2005 takes the place of the publication of the European patent application. | [2006/41] | Search report(s) | International search report - published on: | JP | 16.06.2005 | (Supplementary) European search report - dispatched on: | EP | 25.09.2007 | Classification | IPC: | C12N7/01, C12N15/863, A61K39/285 | [2006/49] | CPC: |
C12N15/86 (EP,US);
A61K39/12 (EP,US);
A61K39/285 (EP,US);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/12 (EP);
|
| Former IPC [2006/41] | C12N7/01, C12N15/863 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2006/41] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | HOCHSICHERES POCKEN-VAKZINE-VIRUS UND VACCINIA-VIRUS-VEKTOR | [2006/41] | English: | HIGHLY SAFE SMALLPOX VACCINE VIRUS AND VACCINIA VIRUS VECTOR | [2006/41] | French: | VIRUS DE VACCIN ANTIVARIOLIQUE HAUTEMENT SUR ET VECTEUR DE VIRUS DE LA VACCINE | [2006/41] | Entry into regional phase | 19.06.2006 | Translation filed | 19.06.2006 | National basic fee paid | 19.06.2006 | Search fee paid | 19.06.2006 | Designation fee(s) paid | 19.06.2006 | Examination fee paid | Examination procedure | 19.06.2006 | Examination requested [2006/41] | 24.01.2008 | Despatch of a communication from the examining division (Time limit: M04) | 30.05.2008 | Reply to a communication from the examining division | 19.02.2009 | Despatch of a communication from the examining division (Time limit: M04) | 01.07.2009 | Reply to a communication from the examining division | 21.09.2010 | Despatch of a communication from the examining division (Time limit: M04) | 24.01.2011 | Reply to a communication from the examining division | 23.11.2011 | Despatch of a communication from the examining division (Time limit: M04) | 07.02.2012 | Reply to a communication from the examining division | 24.04.2012 | Communication of intention to grant the patent | 05.09.2012 | Application deemed to be withdrawn, date of legal effect [2013/09] | 15.10.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2013/09] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.01.2008 | Fees paid | Renewal fee | 19.06.2006 | Renewal fee patent year 03 | 29.12.2006 | Renewal fee patent year 04 | 28.12.2007 | Renewal fee patent year 05 | 31.03.2008 | Renewal fee patent year 06 | 23.12.2009 | Renewal fee patent year 07 | 23.12.2010 | Renewal fee patent year 08 | 23.12.2011 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY] - ENGELSTAD MAIKEN ET AL, "The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence", VIROLOGY, (1993), vol. 194, no. 2, ISSN 0042-6822, pages 627 - 637, XP002443993 [X] 1-11 * the whole document * [Y] 12-24 DOI: http://dx.doi.org/10.1006/viro.1993.1302 | [AY] - KATZ E ET AL, "IMMUNOGENICITY OF RECOMBINANT VACCINIA VIRUSES THAT DISPLAY THE HIV TYPE 1 ENVELOPE GLYCOPROTEIN ON THE SURFACE OF INFECTIOUS VIRIONS", AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, US, (19971120), vol. 13, no. 17, ISSN 0889-2229, pages 1497 - 1500, XP009038314 [A] 1-11 * the whole document * [Y] 12-24 | [AY] - BOURSNELL M E G ET AL, "Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (199611), vol. 14, no. 16, ISSN 0264-410X, pages 1485 - 1494, XP004063302 [A] 1-11 * the whole document * [Y] 12-24 DOI: http://dx.doi.org/10.1016/S0264-410X(96)00117-X | International search | [Y]WO9012101 (LYNXVALE LTD [GB]); | [Y] - SUGIMOTO M. ET AL, "Kokusan Ten'nento Vaccine no Aratana Yakuwari", PROTEIN, NUCLEIC ACID AND ENZYME, (2003), vol. 48, no. 12, pages 1693 - 1701, XP002988169 | [Y] - MATHEW E. ET AL, "The extracellular domain of vaccinia virus protein B5R affects plague phenotype, extracellualr enveloped virus release, and intracellular actin tail formation", J VIROL, (1998), vol. 72, no. 3, pages 2429 - 2438, XP002988057 | [Y] - HERRERA E. ET AL, "Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large protein of the extracellular domain", J VIROL, (199801), vol. 72, no. 1, pages 294 - 302, XP002176446 | [Y] - WOLFFE E.J. ET AL, "Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glyco protein inhibits extracellular virus envelope formation and dissemination", J VIROL, (1993), vol. 67, no. 8, pages 4732 - 4741, XP008049403 | [Y] - MATHEW E.C. ET AL, "A mutational analysis of the vaccinia virus B5R protein", J GEN VIROL, (2001), vol. 82, no. 5, pages 1199 - 1213, XP002988058 | [Y] - LORENZO M.M. ET AL, "Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail", VIROLOGY, (19981220), vol. 252, no. 2, pages 450 - 457, XP004445517 DOI: http://dx.doi.org/10.1006/viro.1998.9483 | by applicant | JPH11509091 | - DNA Cloning 4 -Mammalian System | - "DNA Cloning 4 -Mammalian System", EMBO Journal, (1997), vol. 6, pages 3379 - 3384 |